GlassScriptPhysician profile
Kellye R Bookout
NPI 1033315395
$4,495.29
in general payments reported to CMS, 2019-2025
19 companies · $978 in 2025
The $978 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $516 · 2023: $401 · 2024: $2,404 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,900 · Food and Beverage: $1,602 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,900.00 |
| Food and Beverage | $1,602.49 |
| Education | $279.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,057.34 | 2023-2025 | Bimzelx |
| Janssen Biotech, INC. | $616.77 | 2021-2025 | Tremfya |
| Abbvie INC. | $344.52 | 2022-2025 | |
| Incyte Corporation | $246.72 | 2021-2023 | Opzelura |
| Genzyme Corporation | $196.33 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $180.71 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $150.37 | 2022-2025 | Nemluvio |
| Leo Pharma INC. | $119.45 | 2021-2025 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $112.54 | 2024-2025 | Cabtreo, Jublia, Siliq |
| Sun Pharmaceutical Industries INC. | $104.98 | 2022-2025 | |
| Amgen INC. | $90.35 | 2023-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $82.63 | 2022-2025 | |
| Pfizer INC. | $45.70 | 2022-2024 | |
| Lilly USA, LLC | $43.19 | 2022-2025 | Ebglyss, Taltz |
| Mayne Pharma Commercial LLC | $26.77 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.11 | 2023 | Spevigo |
| Paratek Pharmaceuticals, INC. | $19.26 | 2023 | Nuzyra |
| Organon LLC | $16.53 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $15.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellye Bookout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.